Simon Sutcliffe, MD, FRCP, FRCPC, FRCR
Dr. Sutcliffe is a distinguished clinician, scientist, and leading visionary in cancer control in Canada and internationally. A graduate of St. Bartholomew’s Hospital, London, England, Dr. Sutcliffe’s training encompassed internal medicine, scientific research, medical and radiation oncology in the UK, South Africa, US, and Canada. He has published extensively in the areas of radiation and medical oncology as applied to the treatment of lymphoma, leukemia and cellular immuno-deficiency and immuno-modulation in cancer.
Dr. Sutcliffe was President and CEO of the Ontario Cancer Institute and Princess Margaret Hospital (1994-96) and the BC Cancer Agency (2000-09). Dr. Sutcliffe was the inaugural Chair of the Governing Council of the Canadian Strategy for Cancer Control, a past member of the NCIC Board of Directors, and past chair of the Canadian Partnership against Cancer, the Canadian Cancer Society/National Cancer Institute of Canada Joint Advisory Committee on Cancer Control, and the National Medical Advisory Committee. He has also served on the boards of the Michael Smith Foundation for Health Research and Genome BC.
Dr. Sutcliffe is currently the President of the International Cancer Control Congress Association, President of Two Worlds Cancer Collaboration (the Canadian Branch of the International Network for Cancer Treatment and Research) and the CEO of Premier Diagnostic Centre. He is Past Chair of the Canadian Partnership against Cancer and the Institute for Health Systems Transformation & Sustainability and was senior advisor to the Terry Fox Research Institute. Dr. Sutcliffe was awarded the Queen Elizabeth 50th Jubilee Gold Medal in 2003 and the Terry Fox Award (of the B.C. Medical Association) in 2009 for his lifetime services to cancer control.